Menu ×


Intravascular Surgery Devices Market Segmentation by Device Type (Intravascular Shunt, Catheters, Guide Wires, Heart Valves, and Others); and by End-User (Hospital, Ambulatory Surgical Centers, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Intravascular Surgery Devices Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


  • September, 2021: ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for cabotegravir as an antiviral drug.
  • February, 2021: Koninklijke Philips N.V. announced the acquisition of BioTelemetry, Inc., a leading provider of remote cardiac diagnostics and monitoring, to support cardiac surgeries and treatments.

Global Intravascular Surgery Devices Market Highlights over 2022 – 2030

The global intravascular surgery devices market is estimated to grow at a robust CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the increasing cases of vascular diseases which require surgery, along with rising healthcare expenditure globally. The growing disposable income of individuals across the globe, combined with presence of favorable reimbursement and health insurance policies, are estimated to drive the market growth. Moreover, a large share of heart patients is opting for surgery, owing to the up-surge in health awareness. Along with rising awareness amongst public, increasing initiatives by governments around the globe, are anticipated to boost the market growth. On the other hand, increasing cases of cardiovascular diseases, due to poor lifestyle, including, lack of activities and consumption of fast food, is foreseen to provide growth opportunities for the market. According to a report by the World Health Organization (WHO), CVDs are responsible for over 17.9 million lives each year, making it the leading cause of death worldwide.

Intravascular Surgery Devices MarketMoreover, cardiovascular diseases are the primary cause of premature death currently, out of which, over one third deaths occur below the age of 70 years, as per WHO data. Surgeries are the best course of treatment in case of stroke or heart attack, as the results are instant. Moreover, various technological advancements in the medical sector, have improved the scope and reach of surgeries. Such factors are estimated to strengthen the market growth.

Leading Causes

The market is segmented by end-user into hospital, ambulatory surgical centers, and others, out of which, the ambulatory surgical centers segment is anticipated to hold the largest share in the global intravascular surgery devices market over the forecast period as ambulatory surgical centers are specifically equipped for performing surgeries, generating a significant market for surgical devices and equipment. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Global Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Intravascular Surgery Devices Market Regional Synopsis

On the basis of geographical analysis, the global intravascular surgery devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the rising prevalence of lifestyle diseases in the region, backed by the unhealthy lifestyle prevalent amongst the population. Moreover, higher healthcare expenditure in the region, and presence of patient-friendly reimbursement policies, are estimated to boost the market growth. According to the World Bank, 16.885% of the GDP of United States was spent for healthcare in 2018.

The market in the Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing awareness regarding healthcare amongst people, along with improving healthcare facilities in the region.

Intravascular Surgery Devices Market

The global intravascular surgery devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global intravascular surgery devices market includes the following segments:

By Device Type

  • Intravascular Shunt
  • Catheters
  • Guide Wires
  • Heart Valves
  • Others

By End-User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

Growth Drivers

  • Increasing Incidences of Cardiovascular Diseases
  • Growing Expenditure for Healthcare by Government Authorities as well as Public


  • Lesser Number of Surgeons in Low-income Countries
  • Circulation of Generic Equipment in the Market

Top Featured Companies Dominating the Market

  • Eli Lilly and Company
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Akili Interactive Labs, Inc.
  • Koninklijke Philips N.V.
  • WellDoc, Inc.
  • Noom, Inc.
  • Pear Therapeutics, Inc.
  • Teladoc Health, Inc.
  • Click Therapeutics, Inc.
  • Ayogo Health Inc.


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved